from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3199c/nudC

LFCtreatmentdescriptionclass of inhibitor

0.466

Amikacinug/mL Amikacintranslation

-1.552

Cap5-10ug/mL Capreomycintranslation

-0.259

Rox10-50 ug/mL Roxithromycintranslation

-0.362

SM2-5 ug/mL Streptomycintranslation

2.032

Tet5-10 ug/mL Tetracyclinetranslation

0.967

Rif0.2-5ug/mL Rifampicintranscription

0.714

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.758

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.736

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.150

CPZ10-50 ug/mL Chlorpromazinerespiration

0.436

Clofazimine10-13 ug/mL Clofaziminerespiration

0.389

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.939

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.539

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.939

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.735

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.149

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.802

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.140

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.625

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.406

KCN5-20 ug/mL Potassium cyaniderespiration

0.342

NaN30.2-2 mM Sodium aziderespiration

0.020

Nigericin50 uM Nigericinrespiration

-0.132

TRC10-150 ug/mL Triclosanrespiration

-2.081

TRZ10-25 ug/mL Thioridazinerespiration

-1.791

Valinomycin0.5-10 uM Valinomycinrespiration

1.464

ZnSO42 mM ZnSO4respiration

-1.463

menadione6-10 ug/mL Menadionerespiration

-0.035

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.352

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.192

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.343

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.053

NRP_1Non-replicating persistence stage 1dosRassociated

0.424

Amp0.2mg/mL AmpicillincellWall

-0.169

Cephalexin20-100 ug/mL CephalexincellWall

0.114

Cerulenin0.32-5 ug/mL CerulenincellWall

0.004

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.178

EMB10-20 ug/mL EthambutolcellWall

0.777

Eta12-40 ug/mL EthionamidecellWall

0.803

INH0.2-0.4 ug/mL IsoniazidcellWall

0.363

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.313

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.421

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.341

BZA0.12 mg/mL BenzamidearomaticAmides

0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.473

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.110

H2O24 mM hydrogen peroxideDNAdamaging

0.234

Levo10 ug/mL LevofloxacinDNAdamaging

-0.081

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.123

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.691

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.086

UVUV-irradiationDNAdamaging

-0.218

ARP41-4 ug/mL Antitubercular compound ARP4?

0.160

Antimycin12.5-50 ug/mL Antimycin A?

0.269

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.361

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.482

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.433

PA8240.2-2 ug/mL PA-824?

0.201

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.263

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.041

Verapamil50 uM Verapamil?

-0.239

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.129

methoxatin10-20 ug/mL Methoxatin?